| Disease | cholangiocarcinoma |
| Comorbidity | C0235974|pancreatic cancer |
| Sentences | 1 |
| PubMedID- 24559784 | Given the superior performance characteristics of eus-fna and the higher incidence of pancreatic cancer compared with cholangiocarcinoma, eus-fna should be performed before ercp in all patients with suspected malignant biliary obstruction. |
Page: 1